The aim of the present review was to assess the prognostic impact of lymphovascular
invasion (LVI) in transurethral resection (TUR) of bladder cancer (BC a) specimens on …

Purpose Curative radio-chemotherapy is recognized as a standard treatment option for
muscle-invasive bladder cancer (MIBC). Nevertheless, the technical aspects for MIBC …

BACKGROUND Risk stratification is a major challenge in bladder cancer (BC), and a
biomarker is needed. Multiple studies have reported the neutrophil‐to‐lymphocyte ratio …

Radical cystectomy is a standard treatment for non-metastatic, muscle-invasive bladder
cancer. Treatment with trimodality therapy consisting of maximal transurethral resection of …

Bladder-sparing protocols (BSP) have been gaining widespread popularity as an attractive
alternative to radical cystectomy (RC) for muscle-invasive bladder cancer. Unimodal …

Background Treatment-induced accelerated tumor growth is a progression pattern reported
with immune checkpoint inhibitors that has never been evaluated in randomized phase III …

Abstract Purpose of Review Bladder-sparing trimodality therapy (TMT) has become an
accepted alternative to cystectomy for selected muscle invasive bladder cancer (MIBC) …

Abstract Purpose of the Review This review targets the latest literature on bladder
preservation therapy with emphasis on trimodal therapy (TMT), highlighting its role in the …

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current
evidence and future perspectives - PMC Back to Top Skip to main content NIH NLM Logo …

膀胱癌是全球高发的恶性肿瘤之一, 其中肌层浸润性膀胱癌(muscle invasive bladder cancer,
MIBC) 患者的预后较差. 新辅助治疗后的根治性膀胱切除加盆腔淋巴结清扫术是MIBC …